An electronic health records study of long-term weight gain following antidepressant use

JAMA Psychiatry

Volumn 71, Issue 8, 2014, Pages 889-896

  Blumenthal, Sarah R ^a   Castro, Victor M ^a,b   Clements, Caitlin C ^a   Rosenfield, Hannah R ^a   Murphy, Shawn N ^a,b   Fava, Maurizio ^a   Weilburg, Jeffrey B ^a   Erb, Jane L ^c   Churchill, Susanne E ^b   Kohane, Isaac S ^c   Smoller, Jordan W ^a   Perlis, Roy H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b PARTNERS HEALTHCARE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; NORTRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; BODY MASS; DRUG EFFECTS; ELECTRONIC MEDICAL RECORD; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNITED STATES; WEIGHT GAIN; YOUNG ADULT;

ADULT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BODY MASS INDEX; BUPROPION; CITALOPRAM; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ENGLAND; NORTRIPTYLINE; PROSPECTIVE STUDIES; WEIGHT GAIN; YOUNG ADULT;

EID: 84905819733     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2014.414     Document Type: Article

References (21)

1. Pratt L, Brody D, Gu Q. Antidepressant Use in Persons Aged 12 and Over.Washington, DC: US Department of Health and Human Services; 2011: 2005-2008.
2. Burton BT, Foster WR, Hirsch J, Van Itallie TB. Health implications of obesity: an NIH consensus development conference. Int J Obes. 1985;9(3): 155-170.
3. MustA, Spadano J, Coakley EH, FieldAE, Colditz G, DietzWH.The disease burden associated with overweight and obesity. JAMA. 1999;282(16): 1523-1529.
4. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L; NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003;138(1): 24-32.
5. Whitlock G, Lewington S, Sherliker P, et al; Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669): 1083-1096.
6. deWit LM, van Straten A, van HertenM, Penninx BW, Cuijpers P. Depression and body mass index: a u-shaped association. BMC Public Health. 2009; 9: 14.
7. Luppino FS, deWit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3): 220-229.
8. Simon GE, Von KorffM, Saunders K, et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry. 2006;63(7): 824-830.
9. FavaM.Weight gain and antidepressants. J Clin Psychiatry. 2000;61(suppl 11): 37-41.
10. Serretti A,Mandelli L. Antidepressants and body weight: a comprehensive review andmeta-analysis. J Clin Psychiatry. 2010;71(10): 1259-1272.
11. Montgomery SA, Reimitz PE, ZivkovM. Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study. Int Clin Psychopharmacol. 1998;13(2): 63-73.
12. Uher R, Mors O, Hauser J, et al. Changes in body weight during pharmacological treatment of depression. Int J Neuropsychopharmacol. 2011;14 (3): 367-375.
13. Sussman N, Ginsberg DL, Bikoff J. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor-and imipramine-controlled trials. J Clin Psychiatry. 2001; 62(4): 256-260.
14. Murphy SN, MendisM, Hackett K, et al. Architecture of the open-source clinical research chart from informatics for integrating biology and the bedside. AMIA Annual Symposium Proceedings. In: Bethesda, MD: AMIA;2007: 548-52.
15. Murphy S, Churchill S, Bry L, et al. Instrumenting the health care enterprise for discovery research in the genomic era. Genome Res. 2009;19(9): 1675-1681.
16. Murphy SN,Weber G, MendisM, et al. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J Am Med Inform Assoc. 2010;17(2): 124-130.
17. CharlsonM, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11): 1245-1251.
18. Fitzmaurice GM, Laird NM, Shneyer L. An alternative parameterization of the general linear mixture model for longitudinal data with non-ignorable drop-outs. Stat Med. 2001;20(7): 1009-1021.
19. Boudreau DM, Arterburn D, Bogart A, et al. Influence of body mass index on the choice of therapy for depression and follow-up care. Obesity (Silver Spring). 2013;21(3): 303-313.
20. Dent R, Blackmore A, Peterson J, et al. Changes in body weight and psychotropic drugs: a systematic synthesis of the literature. PLoS One. 2012;7(6): e36889.
21. Osby U, Brandt L, Correia N, Ekbom A, Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58(9): 844-850.